beta-lapachone has been researched along with phenylephrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kuo, ML; Lin-Shiau, SY; Liu, SH; Tzeng, HP | 1 |
2 other study(ies) available for beta-lapachone and phenylephrine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of inducible nitric oxide synthase by beta-lapachone in rat alveolar macrophages and aorta.
Topics: Animals; Aorta, Thoracic; Cell Line; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; In Vitro Techniques; Lipopolysaccharides; Macrophages, Alveolar; Male; Muscle Contraction; Naphthoquinones; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Phenylephrine; Rats; Rats, Wistar; Topoisomerase I Inhibitors; Vasoconstrictor Agents | 1999 |